公司
i-RNA Asia Limited is a Hong Kong-based subsidiary of Canadian biotechnology company i-RNA Corporation, a spin-off from Western University developing innovative siRNA therapeutics for retinal diseases. Building on over 30 years of pioneering research by Distinguished University Professor Dr Subrata Chakrabarti, the company leverages proprietary siRNA technologies, including novel long non-coding RNA (lncRNA) targets and innovative delivery approaches, to advance first-in-class therapeutic candidates for retinal diseases.With Hong Kong serving as an important base for its research, partnerships, and regional growth, i-RNA Asia supports the continued development of the company's therapeutic pipeline, with lead programs in diabetic retinopathy (DR) and age-related macular degeneration (AMD).
簡介
i-RNA Asia Limited is a Hong Kong biotechnology company developing innovative siRNA therapeutics for retinal diseases by leveraging proprietary siRNA technologies targeting long non-coding RNAs (lncRNAs).
